15

Dear Colleagues,

It is a great pleasure and honor for me to announce the

organization of the 5th Mediterranean Multidisciplinary

Oncology Forum (MMOF) Congress, which will be held in

Athens, in November 23-25, 2017.

The 5th MMOF Congress is expected to be a lively

International Forum for oncology professionals across the

Mediterranean, to meet, integrate, discuss and share ideas and communicate new

developments in Oncology for the advancement of cancer care across the

Mediterranean Sea.

An innovative Scientific Program has been designed to cover a wide range of topics,

with a prestigious faculty of Oncology experts, representing various disciplines to

share new practices in the field of Oncology.

The Congress will feature round tables, panel discussions of challenging cases, oral

presentations, posters and special workshops for young oncologists. The program

will also encompass a special scientific event, “The Immuno-Oncology Day‘’, where

the revolution of Immunotherapy will be illustrated by world opinion leaders in the

field.

We are looking forward to welcoming you in Athens, to experience a unique

scientific event and to rejoice in the greatness of Greek culture and civilization in

the historical city of Athens.

Dimitrios I. Bafaloukos, MD, PhD

President of the 5th MMOF Congress

Invitation Letter

Honorary Presidents

P. Kosmidis, Greece

H. Onat, Turkey

President

D. Bafaloukos, Greece

Vice Presidents

G. Asimakopoulos+, Greece

G. Demir, Turkey

Gen. Secretaries

O. Khorshid, Egypt

H. Linardou, Greece

B. Oyan Uluc, Turkey

Gen. Educ. Secretary

A. Christopoulou, Greece

P. Saip, Turkey

Treasurer

O. Nicolatou-Galitis, Greece

Members

I. Yucel, Turkey

M. Garassino, Italy

Organizing Committee(BOARD OF DIRECTORS OF MMOF)

16

17

Local Organizing CommitteeChairman:D. Bafaloukos

Members:Ch. AndreadisI. BoukovinasA. DimopoulosG. KoumakisA. LaskarakisM. Nikolaou F. PoulakakiE. SamantasA. TarampikouK. Tsigaridas

Scientific CommitteeChairpersons:I. Athanasiadis, GreeceH. Linardou, GreeceM. Gümüş, TurkeyR. Gaafar, Egypt

Members:S. Agelaki, GreeceG. Aravantinos, GreeceA. Ardavanis, GreeceV. Barbounis, GreeceS. Bavbek, TurkeyR. Berardi, ItalyN. Bese, TurkeyA. Boleti, UKP. Dimovelis, GreeceK. Frangia, Greece

S. Kakolyris, GreeceH. Khaled, EgyptD. Mavroudis, GreeceΙ. Mountzios, GreeceM. Mokhtar, EgyptS. Murray, UKG. Pentheroudakis, GreeceA. Stratigos, Greece I. Varthalitis, Greece

O. Zoras, Greece

International Advisory committeeMembers:

Abstract Review CommitteeO. Er, TurkeyM. Garassino, ItalyTh. Makatsoris, GreeceS. Murray, UKS. Naguib, EgyptZ. Saridaki, Greece

ΑWARD CommitteeCh. Bakoyiannis, GreeceCh. Christodoulou, GreeceN. Kentepozidis, GreeceO. Khorshid, EgyptH. Linardou, GreeceP. Saip, TurkeyP. Veronesi, Italy

A. Bounedjar, AlgeriaTh. Economopoulos, GreeceZ. Fahed, Syrian Arab RepublicG. Fountzilas, GreeceF. Geara, LebanonV. Georgoulias, GreeceH. Gogas, GreeceM. Gottfried, IsraelG. Leone, ItalyH. Nina, AlbaniaN. Normanno, ItalyB. Oyan Uluc, TurkeyE. Ozyar, TurkeyD. Pectasides, GreeceA. Psyrri, GreeceE. Razis, GreeceK. Syrigos, Greece

18

19

Scientific Program

Thursday 23 November 2 0 1 7

Esperides Hall-

16:00-17:00 Young MMOF – Mentorship session Bridging approaches in the Mediterranean: Brainstorming on interesting cases Chairs: N. Al Lahloubi (EG), M. Nikolaou (GR), K. Tsigaridas (GR)

Neuroendocrine cancer • case presentation (junior oncologist) S. Ziampiri (IT) • mentor’s opinion A. Strimpakos (GR)

Mesothelioma • case presentation (junior oncologist) O. Tsavaris (GR) • mentor’s opinion N. Al Lahloubi (EG)

Gynaecological cancer • case presentation (junior oncologist) T. Kyriazoglou (GR) • mentor’s opinion K. Sakellariou (GR)

17:00-18:00 Advances in GU cancers Chairs: S. Bavbek (TR), A. Christopoulou (GR), N. Kentepozidis (GR)

The robotic era in renal and prostate surgical oncology. V. Poulakis (GR)

Renal cancer: treatment choices and changes in algorithms. E. Boleti (UK)

Castration-resistant prostate cancer: what is new? C. Panopoulos (GR)

18:00-19:00 GI cancer, non-colorectal Chairs: G. Demir (TR), C. Dervenis (GR), P. Papakostas (GR)

Gastric cancer in the Mediterranean basin. Epidemiological data and clinical challenges. S. Yalcin (TR)

Neoadjuvant therapy in gastric cancer. Redux with FLOT. A. Strimpakos (GR)

Opportunities in locally advanced pancreatic cancer. • Surgical perspective: G. Tsiotos (GR) • Medical perspective: M. El-Serafi (EG)

19:00-19.30 Coffee Break

19:30-20:00 Lecture Chairs: H. Khaled (EG), P. Kosmidis (GR), H. Onat (TR)

The European Society of Medical Oncology Magnitude of clinical benefit scale. G. Pentheroudakis (GR)

20

20:00-21:00 In Memoriam George Asimakopoulos Chairs: D. Bafaloukos (GR), B. Gulluoglu (TR), H. Linardou (GR)

Defaults are shifting: As the biology of breast cancer is more disclosed, lesser the loco-regional treatment it requires. B. Gulluoglu (TR)

Santorini Hall)

16:00-17:00 Oral presentations session 1 Chairs: A. Bousboukea (GR), F.Geara (LB), A. Molfeta (GR) O1: 15-YEAR EXPERIENCE WITH MINOR SALIVARY GLAND CANCER AT

SINGLE INSTITUTION: A CLINICAL-PATHOLOGICAL STUDY.I. Kalaitsidou, K. Vahtsevanos, I. Tilaveridis, K. Paraskevopoulos, N. Pastelli, I. Dimitriadis, K. Antoniades

O2: METASTATIC TUMORS TO THE ORAL CAVITYI.Kalaitsidou, K. Paraskevopoulos, K. Vahtsevanos, I.S. Astreidis, V. A. Alexoudi, K. Antoniades

O3: EXPLORING CANCER PREDISPOSITION: PERFORMANCE OF A 94-GENEPANEL ON GREEK BREAST AND OVARIAN CANCER PATIENTS FULFILLINGTHE NCCN CRITERIA FOR GENETIC TESTING.F. Fostira, I. Konstantopoulou, M.S. Pamantzelopoulou, D. Kalfakakou, A. Vagena, P. Apostolou, I. Konstanta, A. Delimitsou, I.S. Vlachos, D. Yannoukakos

O4: NGS ANALYSIS OF HEREDITARY CANCER SYNDROMES: MOREANSWERS THAN QUESTIONS. A. Apessos, K. Agiannitopoulos, G. Pepe, G. Tsaousis, S. Kambouri, D. Gerasoudis, G. Nasioulas

O5: APPLICATION OF NEXT GENERATION SEQUENCING IN LIQUID BIOPSYANALYSIS.E.Papadopoulou, V. Metaxa-Mariatou, N. Tsoulos, A. Tsirigoti, C. Efstathiadou, A. Apessos, K. Agiannitopoulos, G. Pepe, E. Bourkoula, G. Tsaousis, G. Nasioulas

O6: MRI DWIBS IN ASSESSMENT OF CANCER PATIENTS; COULD BEHELPFUL? M. Rezk

O7: THE ROLE OF INTRA OPERATIVE MOBILE GAMMA CAMERA ANDGAMMA PROBE IN DETECTION OF SENTINEL LYMPH NODE IN EARLY STAGEBREAST CANCER (THE EGYPTIAN EXPERIENCE).M. Gamil, M. Hassan, M. Salama, O. Talaat, K. Khalifa Alla, S. Abd AlGaid, A.Mohamed

O8: THE AVOIDANCE OF THE LIP CONTRACTION AFTER THE CUNEIFORMNEOPLASIA EXCISION, USING THE VERMILION FLAP.D. G. Xhepa, H. Nina, A. Hafizi

O9: NIVOLUMAB PLUS IPILIMUMAB IN METASTATIC MELANOMA: SINGLECENTRE EXPERIENCE.D. Bafaloukos, A. Laskarakis, A. Tarampikou, K. Gkiati, A. Molfeta, K. Tsigaridas, A. Bousboukea, H. Linardou

Thursday 23 November 2 0 1 7

Esperides Hall-

21

Friday 24 November 2 0 1 7

Immuno-Oncology day

Esperides Hall-

09:00-14:00 Immuno-Oncology: A new era in cancer Sponsored by

Chairs: I. Athanasiadis (GR), M. Gumus (TR), O. Khorshid (EG)

09:00-09:30 Fundamental concepts on I-O. M. Lotem (IL)

09:30-11:30 Clinical aspects on I-O. • Melanoma: the basis of a new era of success Τ. Kubiatowski (PL) • Progress in Immuno-Oncology Research for

Renal and Bladder Cancers R. Leibowitz (IL) • SCCHN: Does immunotherapy change the

treatment landscape? A. Psyrri (GR) • NSCLC: The perspective of Immunotherapy-

Current challenges J. Bar (IL)

11:30-12:00 Coffee Break

12:00-14:00 Practical considerations in Immuno-Oncology Sponsored by Chairs: D. Bafaloukos (GR), A. Stratigos (GR)

12:00-12:30 Immunotherapy in the adjuvant setting-new options and perspectives. H. Gogas (GR)

12:30-13:30 Toxicity and supportive care of the patient on I-O The perspective of:

• Dermatologist: V. Nikolaou (GR) • Endocrinologist: E. Kassi (GR) • Pneumonologist: A. Charpidou (GR) • Gastrenterologist: G. Bamias (GR)

13:30-14:00 Discussion

14:00-15:30 Lunch Break

14:00-14:45 Parallel satellite lecture Sponsored by

Chairs: Th. Economopoulos (GR), P. Pantelakos (GR)

Advances in NSCLC: The unmet need in early stage ΙΙΙ. H. Linardou (GR)

22

15:30-19:00 Evolution in lung cancer care in the era of CIT. Sponsored by

Chairs: G. Demir (TR), R. Gaafar (EG), H. Linardou (GR)

15:30-16:00 Identifying the right patient for the right treatment. N. Peled (IL)

16:00-16:30 The emerging role of cancer immunotherapy in NSCLC. M. Gottfried (IL)

16:30-17:00 A series of success stories in the personalized approaches for lung cancer: the example of ALK+ NSCLC. E. Felip (SP)

17:00-17:30 Coffee Break

17:30-18:30 Building the treatment algorithm in the era of Sponsored by

cancer immunotherapy.

• EGFR mutant disease: R. Gaafar (EG) • ALK and other biomarker - positive disease: A. Laskarakis (GR) • CIT: G. Mountzios (GR) • Antiangiogenesis: G. Oikonomopoulos (GR)

18:30-19:00 Closing-Overview to current NSCLC treatment guidelines. E. Felip (SP)

19:00-20:30 Opening Ceremony Chairs: D. Bafaloukos (GR), H. Onat (TR), O. Zoras (GR)

Paris Kosmidis Award Keynote Lecture on Lung cancer J.-Y. Douillard (FR)

Welcome addresses

Opening Lecture Literary and artistic representations of women’s cancer V. Rapti (US)

Santorini Hall-

11:30-12:30 Breast Surgeon's Working Group of MMOF

Friday 24 November 2 0 1 7

Esperides Hall-

23

Saturday 25 November 2 0 1 7

Esperides Hall-

09:00-10:30 Colorectal cancer Chairs: G. Demir (TR), N. Mokhtar (EG), Z. Saridaki (GR)

Adjuvant therapy of colon cancer. Molecular classification and good IDEAs. G. Demir (TR)

Integration of systemic therapies with local therapies in unresectable hepatic metastases. G. Tzimas (GR)

Chemotherapy and targeted agents in 1st line. E. Martinelli (IT)

Sequencing of systemic therapies in metastatic disease beyond 1st line. O. Er (TR)

10:30-12:00 Medical oncology in the Mediterranean Chairs: I. Boukovinas (GR), S. Murray (UK)

Multidisciplinarity - a dream or everyday reality? I. Boukovinas (GR)

Prevention/early diagnosis - molecular diagnostic tests for all? the scientist’s view. G. Sozzi (IT)

Access to cancer therapies - inequalities and challenges. K. Athanasakis (GR)

Access to cancer therapies: examples from eastern Mediterranean countries. Z. Fahed (SY)

The patients’ perspective K. Apostolidis (GR)

Commentators: I. Yucel (TR), G. Samonis (GR), M. Garassino (IT), S. Neta (GR)

12:00-12:30 Coffee Break

12:30-14:00 Breast cancer Chairs: H. Khaled (EG), G. Koumakis (GR), H. Nina (AL)

Surgical approach after neoadjuvant chemotherapy for breast cancer. F. Poulakaki (GR)

PARP inhibitors in breast cancer. Clinical data and emerging opportunities. E. Galani (GR)

Her2 targeting in the neoadjuvant and adjuvant setting. Critical analysis of the data. Ch. Christodoulou (GR)

Luminal breast cancers. Appropriate treatment sequencing and individualized decisions. O. Khorshid (EG)

14:00-15:00 Lunch Break and Parallel satellite lectures

14:00-14:30 Chairs: P. Kosmidis (GR), H. Linardou (GR) Immunotherapy in lung cancer: a choice for Sponsored by

everyone? M. Garassino (IT)

14:30-15:00 Chairs: V. Georgoulias (GR), P. Dimovelis (GR) Agreements and disagreements in targeted Sponsored by

melanoma therapies. D. Bafaloukos (GR)

15:00-16:00 Supportive care and toxicity management Chairs: M. Gumus (TR), S. Kaltsas (GR), E. Patiraki (GR)

Advances in pain management. Z. Kontouli (GR)

New drugs, new toxicities- basic management steps. I. Athanasiadis (GR)

Cardiotoxicity in oncology- new ways to approach it. M. Mahmoudi (UK)

The role of specialised oncology nurses. A. Tarampikou (GR)

16:00-17:00 Head and neck cancer Chairs: Μ. El Serafi (EG), I. Giotakis (GR), O. Nicolatou-Galitis (GR)

State of the art radiation therapy for head and neck cancer. A. Dimopoulos (GR)

HPV infection and classification schemas for oropharyngeal cancer. K. Tsigaridas (GR)

Sequencing of therapies and therapeutic algorithm in squamous cell head and neck cancer. A. Psyrri (GR)

17:00-17:30 Closing and Awards (best abstract) Chairs: I. Athanasiadis (GR), R. Gaafar (EG), M. Gumus (TR),

H. Linardou (GR)

Saturday 25 November 2 0 1 7

Esperides Hall-

24

25

09:00-10:00 Oral presentations session 2 Chairs: S. Kosmidis (GR), C. Panopoulos (GR) O10: MUCH MORE THAN WE DO BELIEVE, HORMONE CONTRACEPTION IS

A MAJOR RISK FACTOR FOR BREAST CANCER. UPPER EGYPT POPULATIONSTUDY.I. Malash, E. Desouky

O11: B.C.S. & ONCOPLASTIC RECONSTRUCTION IN BREAST CANCERPATIENTS N.C.I. EXPERIENCE.M.M. Safa, W. Yousry, O. Zakaria, A. Farahat

O12: SURGERY IN BREAST AFTER NEOADJUVANT THERAPY.H. Nina, G. Xhepa, A. Hafizi, O. Manastirliu, B. Aliaj, B. Kreka, A. Pere, L.Toska, E. Gashi, I. Naqellri, A. Luca

O13: GRANULOSA CELL TUMORS OF THE OVARY; RETROSPECTIVEANALYSIS OF 17 CASES.H. Aziz, A. Fathalla

O14: PRIMARY OVARIAN NON-HODGKIN’S LYMPHOMA: A CLINICO-PATHOLOGIC STUDY OF 16 CASES.H. Aziz , A. Fathalla

O15: SEXUALITY IN PATIENTS TREATED FOR COLORECTAL CANCER. G. Tassopoulos, A. Stefanopoulos, M. Hera, A. Hatzopoulos, P. Heras

O16: D2 GASTRECTOMY: LONG TERM RESULTS. A. Touny

O17: MALIGNANT PLEUAL MESOTHELIOMA (MPM) AMONG DECADES.R. M. Gaafar, F.M.A. Abou El-kasem, M. Abdel-Rahman, M. Rahoma, I. Ioai AbouEl-khir

O18: ONCOGENIC MECHANISMS IN MALIGNANT PLEURAL EFFUSION DUETO PRIMARY LUNG ADENOCARCINOMA.E. Chaini, A.M. Athanassiadou, A. Vassias, A. Tsipis, M. Gonidi, K.D. Hainis,A. Charpidou, P. Athanassiadou

Saturday 25 November 2 0 1 7

Santorini Hall)

26

Al Lahloubi N. Professor of Medical Oncology, National Cancer Institute, CairoUniversity, Egypt

Apostolidis K. Vice President ECPC, European Cancer Patient Coalition,President, Hellenic Cancer Federation-ELLOK

Athanasakis K. Health Economist, Research Fellow, National School of PublicHealth, Athens, Greece

Athanasiadis I. Medical Oncologist, Director of Oncology Clinic, Ass. Professor ofOncology, Northwestern University Chicago

Bafaloukos D. Medical Oncologist, Director of 1st Oncology Department,“Metropolitan” Hospital, Professor of Oncology TEI Athens,Greece

Bamias G. MD, PhD, Associate Professor of Gastroenterology, GI Unit, 3rdAcademic Department of Internal Medicine, National andKapodistrian University of Athens, “Sotiria” Hospital, Athens,Greece

Bar J. MD, PhD, Head of Thoracic Oncology Unit, Institute of Oncology,“Chaim Sheba” Medical Center, Tel-Hashomer, Israel.

Bavbek S. Medical Oncologist, TurkeyBoleti E. MD, PhD, MRCP, Consultant in Medical Oncology, Department of

Academic Oncology, Royal Free London NHS Foundation Trust,UK

Boukovinas I. MD, PhD, PharmaD, Head of the Bioclinic Oncology Unit ofThessaloniki, Greece

Bousboukea A. Gastroenterolog-Endoscopist, Consultant 1st OncologyDepartment, “Metropolitan” Hospital

Charpidou A. MD, PhD, FCCP, Chest Physician, Head of Clinical Trials Bureau, 3rd

Department of Internal Medicine, Medical School, National andKapodistrian University of Athens, Greece

Christodoulou Ch. Medical Oncologist, Director of 2nd Oncology Department,“Metropolitan” Hospital, Athens, Greece

Christopoulou A. Medical Director of Medical Oncology in Oncology Unit of ''St.Andrews'' General Hospital of Patras, Greece

Demir G. Professor, Coordinator of Medical Oncology Department,Istanbul Acibadem Maslak Hospital, Turkey

Dervenis C. MD, PhD, FRCS Head, Department of Surgical Oncology and HPBSurgery, “Metropolitan” Hospital, Athens, Greece, PresidentEuropean-African HPB Association

Dimopoulos A. Medical Director of Radiotherapy Department, “Metropolitan”Hospital, Athens, Greece.

Dimovelis P. Director of Plastic Surgery Department, “Metropolitan” Hospital,Athens, Greece

Douillard J.-Y. MD, PhD, Professor Emeritus in Medical Oncology, University ofNantes, France Chief Medical Officer of ESMO

Economopoulos Th. Professor of Medical Oncology, National and KapodistrianUniversity of Athens, Greece

El-Serafi M. Professor of Medicine and Medical Oncology, NCI Egypt,President of Egyptian Cancer Society, Cairo, Egypt

Er O. Professor of Medical Oncology, Head of Department of MedicalOncology, Acıbadem University, Turkey

Fahed Z. MD.CES, DIS/DISC, General secretary of Syrian Society ofSenology consultant in Oncology /Ηematology, Syria

Faculty

27

Felip E. MD, PhD Head, Thoracic and H&N Cancer Group OncologyDepartment, Vall d’Hebron University Hospital, Vall d’HebronInstitute of Oncology (VHIO), Barcelona, Spain

Gaafar R. Professor Medical Oncology, National Cancer Institute, CairoUniversity, Egypt

Galani E. MD, PhD, Medical Oncologist, Assistant Director, 2nd OncologyDepartment, “Metropolitan” Hospital, Athens, Greece

Garassino M. MD Chief, Medical Thoracic Oncology Unit IRCCS, IstitutoNazionale dei Tumori Milan, Italy

Geara F. MD, PhD, Professor and Chairman, Department of RadiationOncology, The American University of Beirut Medical Center,Beirut

Georgoulias V. MD, PhD, Professor of Medical Oncology, University General ofHeraklion, Crete, Greece

Giotakis I. Professor, National and Kapodistrian University of Athens, Ear,Nose & Throat Specialist, Head ENT Clinic, University GeneralHospital “Attikon”, Athens, Greece

Gogas H. MD, Professor in Medical Oncology, National and KapodistrianUniversity of Athens, Greece

Gottfried M. MD, Head of Oncology Department, “Meir” Medical Center, KfarSaba, Israel.

Gulluoglu B. Medical Oncologist, Marmara University, School of Medicine,Department of Surgery, Breast Surgery Unit, SENATURK TurkishAcademy of Senology, Turkey

Gumus M. President of Turkish Medical Oncology Society, TurkeyKaltsas S. Medical Oncologist, Consultant, 3rd Oncology Department,

“Metropolitan” Hospital, Athens, GreeceKassi E. Endocrinologist, Associate Professor of Biochemistry-Molecular

Endocrinology, Medical School, National and KapodistrianUniversity of Athens, Greece

Κentepozidis N. Medical Oncologist, MD, MSc, PhD, Director of Oncology Clinic251 General Airforce Hospital

Khaled H. Professor of Medical Oncology, Cairo University, Former Dean ofthe National Cancer Institute, Cairo University, Former Ministerof Higher Education, Cairo, Egypt

Khorshid O. Professor of Medical Oncology, Hemato-Oncology and BMT,National Cancer Institute, Cairo University, Egypt

Kontouli Z. Consultant in Pain Medicine, “Metropolitan” Hospital Athens,Imperial College, London, UK

Kosmidis P. Medical Oncologist, Director of 2nd Oncology Department,“Ygeia” Hospital, Athens, Greece

Koumakis G. Medical Oncologist, Director of 2nd Oncology Department andBone Marrow Transplantation Unit, “St. Savvas” OncologyHospital, Athens, Greece

Kubiatowski T. Medical Oncologist, St. John of Dukla Cancer Center in Lublin,Poland

Kyriazoglou T. MD, PhD, Medical Oncologist, Dept. of Clinical Therapeutics,General Hospital “Alexandra”, Athens, Greece

Laskarakis A. MD, MSc, Medical Oncologist, Consultant 1st OncologyDepartment, “Metropolitan” Hospital, Athens Greece

Leibowitz R. MD, PhD-GU Cancers, Oncology Institute, Sheba MC, Israel

28

Linardou H. MD, PhD, Consultant Medical Oncologist, Assistant Director of1st Oncology Department, “Metropolitan” Hospital, Athens,Greece

Lotem M. Head, Center for Melanoma and Cancer Immunotherapy SharettInstitute of Oncology Hadassah Hebrew University MedicalCenter, Israel

Mahmoudi M. Professor of Medicine & Associate Professor of InterventionalCardiology, University of Southampton, London, UK

Martinelli E. Medical Oncologist, Department Medical – Surgical of InternalClinic “F. Magrassi e A. Lanzara”, Naples, Italy

Mokhtar N. Professor Emeritus, National Cancer Institute, Cairo University,Egypt

Molfeta A. Internist, Consultant, 1st Oncology Department, “Metropolitan”Hospital, Athens, Greece

Mountzios G. MD, MSc, PhD, Medical Oncologist, 251 Air Force GeneralHospital, Athens, Greece

Murray S. PhD, CEO/CSO BioMarker Solutions LTD, London, UK, LeaderOncology GeneKOR S.A., Athens Greece

Neta S. Journalist, Health Editor, GreeceNikolaou M. MD, MSc, PhD Medical Oncologist, General – Maternity District

Hospital “Helena Venizelou”, Athens, GreeceNikolaou V. Dermatologist, Dermatological Clinic, General Hospital “Andreas

Syggros”Nicolatou-Galitis O. DDS, MSc, DrDent Professor & Head Clinic of Hospital Dentistry &

Dental Oncology Unit , Dental School, National and KapodistrianUniversity of Athens

Nina H. Prof. Ass., Head of Surgical and Intensive Care Unit, in the Serviceof Oncology at University Hospital "Nene Tereza" Tirane,Lecturerof Tirana Medical University, Albania

Oikonomopoulos G. MSc, Consultant Medical Oncologist, 2nd Medical OncologyDepartment, “Metropolitan” Hospital, Athens, Greece

Onat H. MD, Professor, Medical Oncologist, “Anadolu” Medical CenterHospital, Kocaeli, Turkey

Panopoulos C. Medical Oncologist, Head of Oncology Clinic, “Euroclinic”,Athens, Greece

Pantelakos P. Head of Radiation Therapy and Radiosurgery Department,Medical Group of “Iatropolis”, Athens, Greece

Papakostas P. Head of Oncology Unit, “Hippocratio” Hospital, Athens, GreecePatiraki E. Professor of Nursing care delivery systems-Palliative Care, Vice

President, Faculty of Nursing, School of Health Sciences, Nationaland Kapodistrian University of Athens, Greece

Peled N. Pulmonologist and Thoracic Medical Oncologist, Senior MedicalOncologist, Thoracic Cancer Unit, Davidoff Cancer, Head of theResearch and Detection Unit for Thoracic Malignancies, ShebaMedical Center, Tel Hashomer, Israel, Faculty Member, SacklerFaculty of Medicine, Tel Aviv University, Israel, Chair, Prevention,Screening and Early Detection Committee of the InternationalAssociation for the Study of Lung Cancer (IASLC)

29

Pentheroudakis G. Associate Professor of Oncology, Medical School, University ofIoannina, Chair, ESMO Guidelines Committee Member, ESMOExecutive Board

Poulakaki F. M.D, Ph.D, FEBS, Breast Surgeon Head of Breast SurgeryDepartment, Euroclinic Athens, Hospital, Athens GreeceGen.Secretary of Breast Surgeon's Working Group of MMOF

Poulakis V. MD, PhD, FEBU, Urologic Surgeon-Andrologist, AssociateProfessor, University of Frankfurt, Germany

Psyrri A. Medical Oncologist, Ass. Professor, Medical School, National andKapodistrian University of Athens, Greece

Rapti V. Ph.D. Chair, Ludics Seminar, Mahindra Humanities Center,Harvard University

Sakellariou K. MD, MSc, Medical OncologistSamonis G. MD, PhD, Medical Oncologist-Infectious Diseases Specialist,

Professor of Medicine, University of Crete, GreeceSaridaki Z. MD, PhD, Medical Oncologist, Scientific Director of the Oncology

Department, “Asklepios”, Heraklion, Greece.Sozzi G. PhD, Chief Tumor Genoimics Unit, Istituto Nazionale Tumori,

Milano, ItalyStratigos A. Professor of Dermatology-Venereology, University of Athens,

Medical School, “Andreas Sygros” Hospital, Athens, Greece.Strimpakos A. MD, MRCP, PhD. Head of Medical Oncology Dept., Athens

Medical Center, Athens, GreeceTarampikou A. RN, MSc Clinical Research Coordinator, 1st Oncology Department,

“Metropolitan” Hospital, Athens, GreeceTsavaris O. Medical Oncologist, University General Hospital “Attikon”,

Athens, GreeceTsigaridas K. Consultant Oncologist, 1st Oncology Department,

“Metropolitan” Hospital, Athens, GreeceTsiotos G. Director, Department of Surgery, “Mitera” Hospital, Athens,

Greece, Assistant Professor of Surgery, Mayo Clinic, Rochester,MN

Tzimas G. Surgeon, Director, Hepatobiliary Surgery Department, “Ygeia”Hospital, Athens, Greece

Yalcin S. MD, Professor of Oncology, Hacettepe University Institute ofcancer, President of Turkish Association of Cancer Research andTreatment, Turkey

Yucel I. Professor, Ondokuz Mayis University, TurkeyZiampiri S. Medical Oncologist, Medical Oncology Unit 1, Veneto Oncologic,

Padova, ItalyZoras O. Rector, University of Crete, Professor of Surgical Oncology chair

Department, ESSO Board Directors Member

30

Organized by theMediterranean Multidisciplinary Oncology Forum (M.M.O.F.)

Congress websitewww.medmof2017.com

Congress Dates23-25 November 2017

Congress VenueHotel Hilton Athens46, Vassilisis Sofias Avenue, 115 28 AthensTel +30 210 7281000

LanguageThe official language of the Congress is English.

Audiovisual - Technical SupportAll meeting rooms will be equipped with data video projectors, laser pointers etc,for power point presentations. Technical Support Center will be available outsidethe meeting rooms. Technical staff will assist with the presentations. All speakersare kindly requested to submit their presentation at least 1 hour prior to theirscheduled presentation.

AccreditationThe 5th Congress of the Mediterranean Multidisciplinary Oncology Forum willreceive accreditation from the Panhellenic Medical Society.

Name badgesAll registered participants will receive name badges, which they are kindly requestedto wear at all times. Each badge will have a barcode for monitoring the hours of atten-dance.

Congress Secretariat

Ε.Τ.S. Events & Travel Solutions S.A.154 El. Venizelou Str.171 22 Athens, Greece, Tel.: +30 210 98 80 032Fax.: +30 210 98 81 303Ε-mail: ets@events.gr, ets@otenet.gr,Website: www.events.gr

General Informations

31

Certificate of AttendanceAll registered participants who have attended at least 60% of the total programhours will receive a certificate of attendance from the Secretariat Desk after theclosing ceremony.

Registration Cost (VAT included)Type of Registration Up to September 01st 2017 After September 02nd 2017

MMOF Members 130€ 200€ Non-MMOF Members 170€ 240€ Oral Oncologists & Junior Oncologists, Nurses 70€ 130€ Daily registration ticket 50€ Medical Students Free Free

Registration cost includes:• Admission to all conference sessions & exhibition area• Congress proceedings – material, certificate of attendance

Full payment is required for all registrations.

Registration for medical students includes:• Admission to all conference sessions & exhibition area• Certificate of attendance

Accommodation CostLimited number of rooms has been pre-booked at the Hilton Athens Hotel with spe-cial conditions for the Congress’ participants.

Please visit the site www.medmof2017.com to download the booking form inorder to guarantee and confirm your registration.

32

Sponsors